| Abstrakt: |
A recent study conducted by Mayo Clinic examined the sex differences in injection drug use (IDU) in the United States. The study found that females had a higher prevalence among people who inject drugs (PWID) over a span of 21 years. Additionally, females tended to begin their primary substance use later in life and entered treatment after a shorter period of substance use compared to males. The study suggests that interventions should be implemented prior to the transition to IDU, particularly for females, in order to increase treatment-seeking earlier in the disease course. [Extracted from the article] |
